0000898432-15-001421.txt : 20160106 0000898432-15-001421.hdr.sgml : 20160106 20151204171740 ACCESSION NUMBER: 0000898432-15-001421 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 CORRESP 1 filename1.htm
IRADIMED CORPORATION
1025 Willa Springs Drive
 Winter Springs, FL 32708
VIA EDGAR

December 4, 2015

United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, DC 20549
 
Attn:
Ms. Amanda Ravitz
Mr. Tim Buchmiller
Mr. Brian Soares
 
Re:
Iradimed Corporation
Registration Statement on Form S-3
File No. 333-207778
 
Acceleration Request
 
 
Requested Date:
 December 7, 2015 
  Requested Time:  4:30 p.m. Eastern Time 
                                        
 
Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, IRADIMED CORPORATION., a Delaware corporation (the “Company”), hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on December 7, 2015 at 4:30 p.m. Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”) of the Commission.

The Company acknowledges that:

·
Should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

·
The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

·
The Company may not assert Staff comments or the declaration of the effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The Registrant requests that it be notified of such effectiveness by a telephone call to our counsel, K&L Gates LLP, by calling Mr. Leib Orlanski at (310) 552-5044.
 
 
Sincerely,
 
IRADIMED CORPORATION
 
 

 
By:
/s/ Roger Susi  
    Roger Susi  
    President and Chief Executive Officer  
       
 
 
cc:
Leib Orlanski, K&L Gates LLP
Mark L. Hammes, K&L Gates LLP
Trevor D. Belton, K&L Gates LLP